IL6 and diabetic kidney disease: Additionally, TMAO can promote the development of DKD by inducing inflammation (NF-κB, NLRP3, TNF-α, IL-1β, IL-6), oxidative stress, and fibrosis in the renal system (Fang et al., 2021b).